Graham G. Walmsley, a director at Akero Therapeutics, Inc. (NASDAQ:AKRO), recently acquired a significant amount of the company's common stock. According to a recent SEC filing, Walmsley purchased 200 ...
Never let them tell you that nothing ever changes in politics. In 1996, just 27 percent of American adults believed that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback